Your browser is not supported. Please update it.

21 May 2007

Qualcomm boosts efforts in wireless healthcare with LifeComm MVNO

Qualcomm has a track record of investing in spectrum and creating service providers in order to kickstart its own technologies – the MediaFLO wholesale mobile television service is the most recent example, and the chipmaker also invested in European operators to boost the 450MHz version of CDMA. Now it seems to be taking the same tack for hardware and software it has developed for the booming wireless medical sector, creating an MVNO called LifeComm, focused on healthcare and aiming not only to showcase Qualcomm’s technologies to a wider operator base, but generate some profit from them before they are adopted on a wider scale.

Two areas of Qualcomm technology will be supported by the LifeComm venture – chips and other products for next generation wireless medical devices, and the Brew mobile content platform. The latter is one of the linchpins of Qualcomm’s move to reduce reliance on CDMA hardware and create a broader, network-independent mobile multimedia environment and can be tailored to create highly targeted user interfaces and services for specific user bases. LifeComm is likely to be one of the first times we see that aspect of Brew in action.

Qualcomm and “unnamed partners” will next year launch the US-based MVNO, probably riding on the Sprint Nextel CDMA2000 network, and targeted specifically at the healthcare sector. Using wireless to support medical applications is a hot growth area, with applications ranging from monitoring elderly or sick patients remotely, to providing ongoing testing of areas like heart rate. Qualcomm said its MVNO would reach beyond specialized medical uses to embrace consumers with an interest in maintaining personal health and fitness too.

This is a more creative approach than many current MVNOs are taking – the old adage that a successful virtual operator needs to go for a precisely targeted audience, and complement rather than challenge its host, has been somewhat forgotten in the race for the media-savvy 15-30 segment. However, whatever the pros and cons of the idea behind the new unit, Qualcomm’ s interest will not be primarily in the profits to be made from health conscious users. Instead, it will want to showcase some cutting edge applications of its wireless and multimedia technologies, to attract the attention of other operators – as well as, more than likely, sell off its majority stake in LifeComm itself for a neat sum down the line.

As well showing off new dimensions for Brew, the key motive will be for Qualcomm to test the waters of non-phone mobile devices in a probable growth sector, and enhance the credibility of its chips in medical products. The company, which has been the most conservative of the chip majors in sticking to its cellphone home territory, has recently shown rising interest in applying its technologies to other devices. Its Snapdragon platform for consumer devices is the most important product in this push to take part in the whole mobile internet and media experience, not just the handset, but the CDMA giant has also been working on more specialized devices in which wireless will play a greater and greater role. It has a considerable track record in telematics and some industrial products, and several years ago it began looking at the role wireless could play in health – an interest shared strongly with Intel – and set up a health and life sciences unit, headed by Don Jones.

Jones explained last week: “We use the term ‘health’ to include healthcare, consumer health, wellness and fitness kinds of applications.” Qualcomm technology is incorporated into various medical devices, such as a heart monitor from California start-up CardioNet, which wirelessly transmits data to physicians, and whose network is managed by Qualcomm’s QConnect unit. The chipmaker is also a founder of the Wireless-Life Sciences Alliance, an organization that focuses on ways to use wireless technologies to deliver healthcare. Now LifeComm will work with undisclosed medical device specialists to design handsets that would combine the functions of a cellphone with medical monitoring, incorporating technologies such as biosensors and ‘wireless band-aids’, which are attached to or embedded into the skin to monitor elements like blood glucose (and have been a key R&D focus at Intel). “There aren’t too many phones that have that kind of convergence,” Jones told an interview. One plan is to have handsets that would create a personal area network with medical devices such as blood pressure monitors, or with fitness products like pedometers. The overall aim is to combine usefulness with attractive design for consumer appeal.

The specific applications and services the MVNO will offer have not been determined, but Jones says the company wants to establish a high profile brand recognized by anyone interested in their health and wellbeing, with women between 40 and 65 – traditionally a neglected demographic by mobile services – the key target, as they are seen as “influencers” in matters of health. Services could involve fitness monitoring, weight management, diabetes management, as well as full scale medical applications.

LifeComm expects to close a bridge loan in the next few weeks to provide initial funding as a separate company, with Qualcomm the largest shareholder and the other partners coming from the medical sector. Jones told Wireless Week the company will then start pulling together an executive team and will do additional market research.